{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:00:46Z","timestamp":1789405246557,"version":"build-2803163510"},"reference-count":108,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    The emergence of La Crosse virus (LACV) infection has been attributed to the global expansion of mosquito habitats and climate change. This pressing issue underscores the urgency of preemptive actions to combat the infection. Currently, no vaccines or targeted antivirals are available for LACV infection. The present study utilizes advanced immunoinformatics approaches for the design of a multiepitope vaccine (LACV-mVax01) targeting the viral proteins G1, G2, and N. The structural assessment suggested favorable stability characteristics, reflected by an instability score of 17.12 and an aliphatic index of 81.88. Based on the two-dimensional structure, the LACV-mVax01 had an alpha-helical content of ~45%, with favorable beta sheets and coils. The refinement of the LACV-mVax01 resulted in an accurate model (TM-score 0.49, C-score \u22121.86), supported by high-quality metrics (RMSD 0.489, MolProbity 2.230, ERRAT 85.539). Docking analyses indicated potential binding interactions with TLR4, showing a binding energy of \u22121000.0 compared to \u2212939.2 for TLR2. Molecular dynamics simulations were consistent with these observations, suggesting relatively stable interactions and maintenance of structural integrity in both complexes. Codon optimization yielded a codon adaptation index of 0.9848, and the predicted mRNA structure had a free energy of \u2212342.16 kcal\/mol, consistent with a stable conformation. Subsequent\n                    <jats:italic>in silico<\/jats:italic>\n                    immunological analyses suggested humoral and cellular responses, including probable memory B- and T-cell responses. However, sustained immunity was also supported by consecutive cytokine and antibody synthesis. The comprehensive structural, molecular, and immunological evaluations suggest that LACV-mVax01 is a promising vaccine candidate capable of eliciting sustained protective immunity against LACV infection. Though future\n                    <jats:italic>in vitro<\/jats:italic>\n                    ,\n                    <jats:italic>in vivo<\/jats:italic>\n                    , and clinical validations are required to perceive its effectiveness and safety.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0350287","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T17:31:51Z","timestamp":1779989511000},"page":"e0350287","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["System immunoinformatics\u2013based design of a multi-epitope vaccine candidate against La Crosse virus"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-1895","authenticated-orcid":true,"given":"Md. Habib Ullah","family":"Masum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homaira Pervin","family":"Heema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Abdullah","family":"Mahdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5139-7368","authenticated-orcid":true,"given":"Syed Mohammad","family":"Lokman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarin","family":"Tasnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rakibul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjida Hossain","family":"Arpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehana","family":"Parvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannatul","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6509-9740","authenticated-orcid":true,"given":"Mohammad Sharif","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"3","key":"pone.0350287.ref001","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-0498","article-title":"Neuroinvasive arboviral disease in the United States: 2003 to 2012","volume":"134","author":"JT Gaensbauer","year":"2014","journal-title":"Pediatrics"},{"issue":"1","key":"pone.0350287.ref002","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CMR.7.1.89","article-title":"Medically important arboviruses of the United States and Canada","volume":"7","author":"CH Calisher","year":"1994","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"pone.0350287.ref003","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM200103153441103","article-title":"La Crosse encephalitis in children","volume":"344","author":"JE McJunkin","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"pone.0350287.ref004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jmedent\/9.2.125","article-title":"Transmission of Lacrosse virus (California encephalitis group) by the mosquito Aedes triseriatus","volume":"9","author":"DM Watts","year":"1972","journal-title":"J Med Entomol"},{"issue":"4","key":"pone.0350287.ref005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1603\/0022-2585-37.4.559","article-title":"La Crosse encephalitis virus habitat associations in Nicholas County, West Virginia","volume":"37","author":"RS Nasci","year":"2000","journal-title":"J Med Entomol"},{"issue":"1","key":"pone.0350287.ref006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1086\/515087","article-title":"Newly recognized focus of La Crosse encephalitis in Tennessee","volume":"28","author":"TF Jones","year":"1999","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"pone.0350287.ref007","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac403","article-title":"La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical\/Neurobehavioral Outcomes and Predictors of Disease Severity","volume":"76","author":"AE Boutzoukas","year":"2023","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"pone.0350287.ref008","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrmicro3332","article-title":"Orthobunyaviruses: recent genetic and structural insights","volume":"12","author":"RM Elliott","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"pone.0350287.ref009","article-title":"La Crosse virus: a scoping review of the global evidence","volume":"147","author":"S Harding","year":"2018","journal-title":"Epidemiol Infect"},{"key":"pone.0350287.ref010","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1099\/vir.0.80407-0","article-title":"Complementarity, sequence and structural elements within the 3\u2019 and 5\u2019 non-coding regions of the Bunyamwera orthobunyavirus S segment determine promoter strength","volume":"85","author":"A Kohl","year":"2004","journal-title":"J Gen Virol"},{"issue":"2","key":"pone.0350287.ref011","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/viro.1996.0336","article-title":"Analysis of the intracellular transport properties of recombinant La Crosse virus glycoproteins","volume":"220","author":"K Bupp","year":"1996","journal-title":"Virology"},{"issue":"1","key":"pone.0350287.ref012","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a receptor for phleboviruses","volume":"10","author":"P-Y Lozach","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"15","key":"pone.0350287.ref013","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1128\/JVI.00140-12","article-title":"Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes","volume":"86","author":"BS Hollidge","year":"2012","journal-title":"J Virol"},{"issue":"18","key":"pone.0350287.ref014","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1128\/JVI.00573-07","article-title":"Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus glycoproteins Gn and Gc in virus assembly and morphogenesis","volume":"81","author":"X Shi","year":"2007","journal-title":"J Virol"},{"issue":"10","key":"pone.0350287.ref015","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1128\/JVI.01933-06","article-title":"La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts","volume":"81","author":"G Blakqori","year":"2007","journal-title":"J Virol"},{"issue":"16","key":"pone.0350287.ref016","doi-asserted-by":"crossref","first-page":"10420","DOI":"10.1128\/JVI.79.16.10420-10428.2005","article-title":"Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs","volume":"79","author":"G Blakqori","year":"2005","journal-title":"J Virol"},{"issue":"6","key":"pone.0350287.ref017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00086-20","article-title":"Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening","volume":"64","author":"ZJ Sandler","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0350287.ref018","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/JVI.02327-10","article-title":"A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys","volume":"86","author":"RS Bennett","year":"2012","journal-title":"J Virol"},{"key":"pone.0350287.ref019","year":"2021"},{"key":"pone.0350287.ref020","first-page":"60","article-title":"BioEdit: An important software for molecular biology","volume":"2","author":"A Alzohairy","year":"2011","journal-title":"GERF Bulletin of Biosciences"},{"issue":"7","key":"pone.0350287.ref021","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA11: Molecular Evolutionary Genetics Analysis Version 11","volume":"38","author":"K Tamura","year":"2021","journal-title":"Mol Biol Evol"},{"issue":"9","key":"pone.0350287.ref022","first-page":"3360","article-title":"NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data","volume":"199","author":"V Jurtz","year":"2017","journal-title":"Journal of Immunology (Baltimore, Md\u00a0: 1950)"},{"key":"pone.0350287.ref023","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"B Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"pone.0350287.ref024","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"IA Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"pone.0350287.ref025","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2--a server for in silico prediction of allergens","volume":"20","author":"I Dimitrov","year":"2014","journal-title":"J Mol Model"},{"issue":"5","key":"pone.0350287.ref026","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac174","article-title":"ToxinPred2: an improved method for predicting toxicity of proteins","volume":"23","author":"N Sharma","year":"2022","journal-title":"Brief Bioinform"},{"key":"pone.0350287.ref027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"SK Dhanda","year":"2013","journal-title":"Biol Direct"},{"key":"pone.0350287.ref028","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.meegid.2017.10.022","article-title":"Overlapping CD8 and CD4 T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach","volume":"56","author":"UK Adhikari","year":"2017","journal-title":"Infection, genetics and evolution\u00a0: journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"key":"pone.0350287.ref029","doi-asserted-by":"crossref","first-page":"6718083","DOI":"10.1155\/2018\/6718083","article-title":"Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus","volume":"2018","author":"UK Adhikari","year":"2018","journal-title":"J Immunol Res"},{"key":"pone.0350287.ref030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"H-H Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"pone.0350287.ref031","first-page":"531","article-title":"Protein identification and analysis tools in the ExPASy server","volume":"112","author":"MR Wilkins","year":"1999","journal-title":"Methods Mol Biol"},{"issue":"4","key":"pone.0350287.ref032","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/bioinformatics\/14.4.378","article-title":"SOSUI: classification and secondary structure prediction system for membrane proteins","volume":"14","author":"T Hirokawa","year":"1998","journal-title":"Bioinformatics"},{"issue":"17","key":"pone.0350287.ref033","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","article-title":"SOLpro: accurate sequence-based prediction of protein solubility","volume":"25","author":"CN Magnan","year":"2009","journal-title":"Bioinformatics"},{"issue":"4","key":"pone.0350287.ref034","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/bioinformatics\/18.4.608","article-title":"Amphiphilicity index of polar amino acids as an aid in the characterization of amino acid preference at membrane-water interfaces","volume":"18","author":"S Mitaku","year":"2002","journal-title":"Bioinformatics"},{"issue":"6","key":"pone.0350287.ref035","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","article-title":"AllergenFP: allergenicity prediction by descriptor fingerprints","volume":"30","author":"I Dimitrov","year":"2014","journal-title":"Bioinformatics"},{"key":"pone.0350287.ref036","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"S Saha","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0350287.ref037","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1038\/s41598-022-12651-1","article-title":"In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches","volume":"12","author":"AA Omoniyi","year":"2022","journal-title":"Sci Rep"},{"key":"pone.0350287.ref038","article-title":"The PSIPRED Protein Analysis Workbench: 20 years on","volume":"47","author":"DWA Buchan","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"pone.0350287.ref039","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0968-0004(99)01540-6","article-title":"NPS@: network protein sequence analysis","volume":"25","author":"C Combet","year":"2000","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"pone.0350287.ref040","first-page":"681","article-title":"SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments","volume":"11","author":"C Geourjon","year":"1995","journal-title":"Comput Appl Biosci"},{"key":"pone.0350287.ref041","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0076-6879(96)66034-0","article-title":"GOR method for predicting protein secondary structure from amino acid sequence","volume":"266","author":"J Garnier","year":"1996","journal-title":"Methods Enzymol"},{"issue":"2","key":"pone.0350287.ref042","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10989-019-09915-2","article-title":"Designing a Novel Multi-epitope T Vaccine for \u201cTargeting Protein for Xklp-2\u201d (TPX2) in Hepatocellular Carcinoma Based on Immunoinformatics Approach","volume":"26","author":"P Ghahremanifard","year":"2019","journal-title":"Int J Pept Res Ther"},{"key":"pone.0350287.ref043","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkn254","article-title":"Immune epitope database analysis resource (IEDB-AR)","volume":"36","author":"Q Zhang","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"pone.0350287.ref044","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"J Ko","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0350287.ref045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"RA Laskowski","year":"1993","journal-title":"J Appl Crystallogr"},{"key":"pone.0350287.ref046","first-page":"684","article-title":"PROCHECK: validation of protein\u2010structure coordinates","author":"RA Laskowski","year":"2012","journal-title":"J Int Fed Clin"},{"issue":"4","key":"pone.0350287.ref047","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00228148","article-title":"AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR","volume":"8","author":"RA Laskowski","year":"1996","journal-title":"J Biomol NMR"},{"issue":"4","key":"pone.0350287.ref048","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/prot.340120407","article-title":"Stereochemical quality of protein structure coordinates","volume":"12","author":"AL Morris","year":"1992","journal-title":"Proteins"},{"issue":"4","key":"pone.0350287.ref049","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/prot.340170404","article-title":"Recognition of errors in three-dimensional structures of proteins","volume":"17","author":"MJ Sippl","year":"1993","journal-title":"Proteins"},{"key":"pone.0350287.ref050","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"M Wiederstein","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"pone.0350287.ref051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002829","article-title":"Reliable B cell epitope predictions: impacts of method development and improved benchmarking","volume":"8","author":"JV Kringelum","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"pone.0350287.ref052","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"J Ponomarenko","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"pone.0350287.ref053","doi-asserted-by":"crossref","DOI":"10.1016\/j.str.2020.06.006","article-title":"Performance and its limits in rigid body protein-protein docking","volume":"28","author":"IT Desta","year":"2020","journal-title":"Structure"},{"issue":"12","key":"pone.0350287.ref054","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/prot.24403","article-title":"How good is automated protein docking?","volume":"81","author":"D Kozakov","year":"2013","journal-title":"Proteins"},{"issue":"2","key":"pone.0350287.ref055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"D Kozakov","year":"2017","journal-title":"Nat Protoc"},{"issue":"3","key":"pone.0350287.ref056","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/prot.25219","article-title":"New additions to the ClusPro server motivated by CAPRI","volume":"85","author":"S Vajda","year":"2017","journal-title":"Proteins"},{"issue":"12","key":"pone.0350287.ref057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015692","article-title":"Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis","volume":"5","author":"F Fransen","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"pone.0350287.ref058","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/pharmaceutics14020423","article-title":"Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases","volume":"14","author":"J-X Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"pone.0350287.ref059","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"MJ Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"2","key":"pone.0350287.ref060","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acs.jcim.0c01390","article-title":"Parameterization of Monovalent Ions for the OPC3, OPC, TIP3P-FB, and TIP4P-FB Water Models","volume":"61","author":"A Sengupta","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"21","key":"pone.0350287.ref061","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1021\/jz501780a","article-title":"Building Water Models: A Different Approach","volume":"5","author":"S Izadi","year":"2014","journal-title":"J Phys Chem Lett"},{"issue":"4","key":"pone.0350287.ref062","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.carres.2008.12.025","article-title":"GROMOS96 43a1 performance on the characterization of glycoprotein conformational ensembles through molecular dynamics simulations","volume":"344","author":"L Pol-Fachin","year":"2009","journal-title":"Carbohydr Res"},{"issue":"1","key":"pone.0350287.ref063","doi-asserted-by":"crossref","first-page":"014101","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"G Bussi","year":"2007","journal-title":"J Chem Phys"},{"issue":"8","key":"pone.0350287.ref064","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"HJC Berendsen","year":"1984","journal-title":"The Journal of Chemical Physics"},{"issue":"12","key":"pone.0350287.ref065","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"M Parrinello","year":"1981","journal-title":"Journal of Applied Physics"},{"issue":"12","key":"pone.0350287.ref066","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A linear constraint solver for molecular simulations","volume":"18","author":"B Hess","year":"1997","journal-title":"J Comput Chem"},{"issue":"9","key":"pone.0350287.ref067","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1063\/1.470043","article-title":"Accuracy and efficiency of the particle mesh Ewald method","volume":"103","author":"HG Petersen","year":"1995","journal-title":"The Journal of Chemical Physics"},{"issue":"1","key":"pone.0350287.ref068","doi-asserted-by":"crossref","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"W Humphrey","year":"1996","journal-title":"J Mol Graph"},{"issue":"9","key":"pone.0350287.ref069","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: An Efficient Program for End-State Free Energy Calculations","volume":"8","author":"BR Miller","year":"2012","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"pone.0350287.ref070","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1261\/rna.065896.118","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 8. Predicting binding free energies and poses of protein-RNA complexes","volume":"24","author":"F Chen","year":"2018","journal-title":"RNA"},{"issue":"1","key":"pone.0350287.ref071","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"T Hou","year":"2011","journal-title":"J Chem Inf Model"},{"issue":"31","key":"pone.0350287.ref072","doi-asserted-by":"crossref","first-page":"16719","DOI":"10.1039\/C4CP01388C","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 4. Accuracies of MM\/PBSA and MM\/GBSA methodologies evaluated by various simulation protocols using PDBbind data set","volume":"16","author":"H Sun","year":"2014","journal-title":"Phys Chem Chem Phys"},{"issue":"1","key":"pone.0350287.ref073","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1038\/s41598-017-09199-w","article-title":"Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection","volume":"7","author":"M Ali","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0350287.ref074","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s41598-020-80899-6","article-title":"In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology","volume":"11","author":"S Bibi","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0350287.ref075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"N Rapin","year":"2010","journal-title":"PLoS One"},{"key":"pone.0350287.ref076","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijbiomac.2020.07.117","article-title":"Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach","volume":"164","author":"S Sanami","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"pone.0350287.ref077","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkn188","article-title":"The Vienna RNA websuite","volume":"36","author":"AR Gruber","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0350287.ref078","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-7188-6-26","article-title":"ViennaRNA Package 2.0","volume":"6","author":"R Lorenz","year":"2011","journal-title":"Algorithms Mol Biol"},{"issue":"7","key":"pone.0350287.ref079","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275237","article-title":"In silico designing and immunoinformatics analysis of a novel peptide vaccine against metallo-beta-lactamase (VIM and IMP) variants","volume":"18","author":"H Motamedi","year":"2023","journal-title":"PLoS One"},{"key":"pone.0350287.ref080","author":"government TUS","year":"2024"},{"issue":"6","key":"pone.0350287.ref081","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"I Delany","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"19","key":"pone.0350287.ref082","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","article-title":"Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012","volume":"32","author":"HJ Larson","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"pone.0350287.ref083","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1128\/JVI.73.8.6984-6991.1999","article-title":"Human MxA protein protects mice lacking a functional alpha\/beta interferon system against La crosse virus and other lethal viral infections","volume":"73","author":"HP Hefti","year":"1999","journal-title":"J Virol"},{"issue":"5167","key":"pone.0350287.ref084","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"U M\u00fcller","year":"1994","journal-title":"Science"},{"issue":"8","key":"pone.0350287.ref085","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1080\/07391102.2020.1756411","article-title":"Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study","volume":"39","author":"M Enayatkhani","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"5","key":"pone.0350287.ref086","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.31557\/APJCP.2021.22.5.1495","article-title":"Reverse Vaccinology Approach in Constructing a Multi-Epitope Vaccine Against Cancer-Testis Antigens Expressed in Non-Small Cell Lung Cancer","volume":"22","author":"LRM Herrera","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"pone.0350287.ref087","doi-asserted-by":"crossref","first-page":"120660","DOI":"10.1016\/j.lfs.2022.120660","article-title":"Modern vaccine development via reverse vaccinology to combat antimicrobial resistance","volume":"302","author":"AJ Tobuse","year":"2022","journal-title":"Life Sci"},{"issue":"5","key":"pone.0350287.ref088","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"LR Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"7830","key":"pone.0350287.ref089","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"KS Corbett","year":"2020","journal-title":"Nature"},{"issue":"27","key":"pone.0350287.ref090","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"FP Polack","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"pone.0350287.ref091","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"COVID-19 mRNA vaccines: Platforms and current developments","volume":"30","author":"GT Szab\u00f3","year":"2022","journal-title":"Molecular Therapy"},{"issue":"8","key":"pone.0350287.ref092","article-title":"A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy","volume":"9","author":"SJ Lee","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"pone.0350287.ref093","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/0929866526666190228144219","article-title":"Applicability of Instability Index for In vitro Protein Stability Prediction","volume":"26","author":"DG Gamage","year":"2019","journal-title":"Protein Pept Lett"},{"key":"pone.0350287.ref094","doi-asserted-by":"crossref","first-page":"101422","DOI":"10.1016\/j.imu.2023.101422","article-title":"Designing of a multiepitope-based chimeric vaccine against dengue virus serotype 3 (DENV-3) through next generation reverse vaccinology approaches","volume":"44","author":"MHU Masum","year":"2024","journal-title":"Informatics in Medicine Unlocked"},{"key":"pone.0350287.ref095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.meegid.2017.02.007","article-title":"A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: an in silico approach","volume":"49","author":"B Meza","year":"2017","journal-title":"Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases"},{"issue":"7","key":"pone.0350287.ref096","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/bioinformatics\/btq066","article-title":"How significant is a protein structure similarity with TM-score = 0.5?","volume":"26","author":"J Xu","year":"2010","journal-title":"Bioinformatics"},{"key":"pone.0350287.ref097","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"VB Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"pone.0350287.ref098","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1107\/S0907444995016477","article-title":"Use of non-crystallographic symmetry in protein structure refinement","volume":"52","author":"GJ Kleywegt","year":"1996","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"3","key":"pone.0350287.ref099","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: phi,psi and Cbeta deviation","volume":"50","author":"SC Lovell","year":"2003","journal-title":"Proteins"},{"issue":"7","key":"pone.0350287.ref100","article-title":"An mRNA vaccine for pancreatic cancer designed by applying in silico immunoinformatics and reverse vaccinology approaches","volume":"19","author":"MHU Masum","year":"2024","journal-title":"PLoS One"},{"key":"pone.0350287.ref101","doi-asserted-by":"crossref","first-page":"012025","DOI":"10.1088\/1757-899X\/458\/1\/012025","article-title":"Sequence analysis and comparative modelling of nucleocapsid protein from pseudomonas stutzeri","volume":"458","author":"S Omar","year":"2018","journal-title":"IOP Conf Ser: Mater Sci Eng"},{"key":"pone.0350287.ref102","doi-asserted-by":"crossref","first-page":"863234","DOI":"10.3389\/fimmu.2022.863234","article-title":"Immunoinformatic Design of a Multivalent Peptide Vaccine Against Mucormycosis: Targeting FTR1 Protein of Major Causative Fungi","volume":"13","author":"Y Araf","year":"2022","journal-title":"Front Immunol"},{"key":"pone.0350287.ref103","doi-asserted-by":"crossref","first-page":"107098","DOI":"10.1016\/j.micpath.2024.107098","article-title":"Developing a chimeric multiepitope vaccine against Nipah virus (NiV) through immunoinformatics, molecular docking and dynamic simulation approaches","volume":"197","author":"MHU Masum","year":"2024","journal-title":"Microb Pathog"},{"issue":"9","key":"pone.0350287.ref104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310398","article-title":"Designing of a chimeric multiepitope vaccine against bancroftian lymphatic filariasis through immunoinformatics approaches","volume":"19","author":"R Parvin","year":"2024","journal-title":"PLoS One"},{"issue":"6","key":"pone.0350287.ref105","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular Dynamics Simulation for All","volume":"99","author":"SA Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"pone.0350287.ref106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.11.014","article-title":"Protein aggregation and its inhibition in biopharmaceutics","volume":"289","author":"W Wang","year":"2005","journal-title":"Int J Pharm"},{"issue":"6110","key":"pone.0350287.ref107","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1126\/science.1219021","article-title":"The protein-folding problem, 50 years on","volume":"338","author":"KA Dill","year":"2012","journal-title":"Science"},{"issue":"9","key":"pone.0350287.ref108","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrg3049","article-title":"Understanding the transcriptome through RNA structure","volume":"12","author":"Y Wan","year":"2011","journal-title":"Nat Rev Genet"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T17:32:07Z","timestamp":1779989527000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350287"}},"subtitle":[],"editor":[{"given":"Shahina","family":"Akter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":108,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350287","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}